Abstract I: Preclinical Discovery and Innovation

Speaker(s)

• 

  Robert Bray, PhD., F(ACHI), HCLD/CC(ABB)

  Emory University
• 

  Matthew Cusick, PhD F(ACHI)

  University of Michigan
• 

  Shi-Yuan (Tina) Meng, PhD

  Thermo Fisher Scientific
• 

  Anna Morris, PhD

  HLA Laboratory Director
  Emory University
  Atlanta, GU
• 

  Omar Moussa, MSc, PhD, F(ACHI)

  Medical University of South Carolina

Moderator(s)

• 

  Ahmed Mostafa, MD, PhD, F(ACHI)

  University of Saskatchwean
• 

  Jenny Tran, PhD

  Vancouver Coastal Health

Presentations:

• 2:45 PM - 3:00 PM US PDT

  Role of epidermal growth factor in cardiac allograft injury
  

  Speaker: Omar Moussa, MSc, PhD, F(ACHI) – Medical University of South Carolina
• 3:00 PM - 3:15 PM US PDT

  HLA-C Peptide Repertoires as Predictors of Clinical Response During Early SARS-CoV-2 Infection
  

  Speaker: Matthew Cusick, PhD F(ACHI) – University of Michigan
• 3:30 PM - 3:45 PM US PDT

  Concentration-dependent antibody specificity profiles of human leukocyte DQ antigens and predictions of functional epitopes
  

  Speaker: Shi-Yuan (Tina) Meng, PhD – Thermo Fisher Scientific
• 3:45 PM - 4:00 PM US PDT

  Defining functional epitopes of human leukocyte DQ antigens using a new single antigen bead panel and engineered variants
  

  Speaker: Shi-Yuan (Tina) Meng, PhD – Thermo Fisher Scientific
• 4:00 PM - 4:15 PM US PDT

  Use of Single Antigen Beads Coated with Engineered Variants for Mapping a Functional Epitope of an HLA-DQA1*01 Specific Antibody
  

  Speaker: Robert Bray, PhD., F(ACHI), HCLD/CC(ABB) – Emory University